0
0
8/9/23 at 7:20pm
Organization
Vox
Author
Keren Landman
42 words
0
Comments
A clinical trial suggests the popular diabetes and weight loss drug semaglutide (branded as Wegovy and Ozempic) reduced the risk of serious heart problems by 20 percent.
You are the first to view
https://www.vox.com/health/23826023/wegovy-ozempic-heart-disease-attack-stroke-death-lower-risk-diabetes
Create an account
or login to join the discussion